EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine

Charlotte Delrue, Marijn M Speeckaert iD

Journal of Personalized Medicine · 19.12.2024 · 14 (12) · 1157

DOI: 10.3390/jpm14121157 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 19.12.2024. Verfasst von Charlotte Delrue und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a major worldwide health concern because of its progressive nature and complex biology. Traditional diagnostic and therapeutic approaches usually fail to account for disease heterogeneity, resulting in low efficacy. Precision medicine offers a novel approach to studying kidney disease by combining omics technologies such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics. By identifying discrete disease subtypes, molecular biomarkers, and therapeutic targets, these technologies pave the way for personalized treatment approaches. Multi-omics integration has enhanced our understanding of CKD by revealing intricate molecular linkages and pathways that contribute to treatment resistance and disease progression. While pharmacogenomics offers insights into expected responses to personalized treatments, single-cell and spatial transcriptomics can be utilized to investigate biological heterogeneity. Despite significant development, challenges persist, including data integration concerns, high costs, and ethical quandaries. Standardized data protocols, collaborative data-sharing frameworks, and advanced computational tools such as machine learning and causal inference models are required to address these challenges. With the advancement of omics technology, nephrology may benefit from improved diagnostic accuracy, risk assessment, and personalized care. By overcoming these barriers, precision medicine has the potential to develop novel techniques for improving patient outcomes in kidney disease treatment.

Schlagwörter

Stichwörter der Autor:innen

kidney disease biomarkersmulti-omicsprecision medicine

Autor:innen und Institutionen

  • Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Research Foundation-Flanders (FWO), 1000 Brussels, Belgium.

ORCID-Profile: Marijn M Speeckaert

Zitieren

APA

Delrue, C., & Speeckaert, M. M. (2024). Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine. Journal of Personalized Medicine, 14(12), 1157. https://doi.org/10.3390/jpm14121157

Vancouver

Delrue C, Speeckaert MM. Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine. Journal of Personalized Medicine. 2024;14(12):1157. doi:10.3390/jpm14121157

BibTeX
@article{Delrue2024,
  author = {Delrue, Charlotte and Speeckaert, Marijn M},
  title = {Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine},
  journal = {Journal of Personalized Medicine},
  year = {2024},
  volume = {14},
  number = {12},
  pages = {1157},
  doi = {10.3390/jpm14121157}
}
Kostenlos starten →